Tag: biotechnology
-
Drug Licensed for Precision Autism Spectrum Therapies
A company making precision therapies for neurological disorders is acquiring rights to a compound first designed as a treatment for cancer, inflammation, and oxidative stress.
-
RNA Cancer Immunotherapy Shown Feasible in Preclinical Test
Tests with lab animals show synthetic viral RNA particles, encased in natural oils, can safely invoke an immune response to attack solid tumors.
-
Nasal Spray Vaccines Get CEPI, NIH Funding
A developer of infectious disease vaccines is gaining funds for new nasal sprays protecting against a range of coronaviruses and the sexually-transmitted disease gonorrhea.
-
Algae-Grown Non-Needle Malaria Vaccine in Preclinical Test
A vaccine grown in genetically-altered algae, designed as a nasal-spray and edible drug, is shown to protect lab mice against parasite infections causing malaria.
-
Patent Issued for Crispr-Edited Viruses in Microbiome
A biotechnology company developing gene-edited therapies for bacterial infections in the gut received a U.S. patent for viruses engineered as treatments.
-
Infographic – Biotech Index Q3 Rollercoaster
For the year-to-date, as noted in today’s chart, NBI shows a general decline, losing more than one-fifth of its value since January.
-
Start-Up Developing Efficient RNA Process, Raises $12M
A company formed earlier this year is commercializing a more efficient process for making synthetic RNA molecules and raising $12 million in seed funds.
-
Stem Cell Lab Planned for Commercial Space Station
A collaboration between university researchers and a space science company is designing a stem cell research lab on a proposed commercial space station.
-
Company Formed to Boost Clinical Trial Success Odds
A pharma/tech industry group is starting a new company to use algorithms for finding gaps in preclinical data that can impair clinical trial progress.
-
Start-Up Licenses Gene-Edited Drug Discovery Tech.
A new company is acquiring a technology using genome-edited tadpoles that finds current drugs addressing precise genetic conditions underlying rare diseases.